Treatment of schistosomiasis in African infants and preschool-aged children: Downward extension and biometric optimization of the current praziquantel dose pole

International Health

Volumn 4, Issue 2, 2012, Pages 95-102

  Sousa Figueiredo, José C ^a,b   Betson, Martha ^a   Stothard, J Russell ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Child health; Mass drug administration; Neglected tropical diseases; Preventive chemotherapy; Tablet pole; Treatment pole

Indexed keywords

PRAZIQUANTEL;

AFRICA; ARTICLE; BIOMETRY; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD HEALTH CARE; DOSE CALCULATION; DRUG COST; DRUG DOSE COMPARISON; ECONOMIC EVALUATION; ENDEMIC DISEASE; FEMALE; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASSIVE DRUG ADMINISTRATION; OPTIMAL DRUG DOSE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHISTOSOMIASIS; SINGLE DRUG DOSE; TABLET; TABLET POLE; TROPICAL DISEASE; UGANDA;

EID: 84861693233     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1016/j.inhe.2012.03.003     Document Type: Article

References (44)

1. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
2. Fenwick A., Rollinson D., Southgate V.R. Implementation of human schistosomiasis control: challenges and prospects. Adv Parasitol 2006, 61:567-622.
3. Fenwick A., Webster J.P., Bosque-Oliva E., et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitol 2009, 136:1719-1730.
4. Kabatereine N.B., Fleming F.M., Nyandindi U., Mwanza J.C., Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol 2006, 22:332-339.
5. Parker M., Allen T., Hastings J. Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. J Biosoc Sci 2008, 40:161-181.
6. Cioli D., Pica-Mattoccia L. Praziquantel. Parasitol Res 2003, 90:S3-S9.
7. Stelma F.F., Talla I., Sow S., et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995, 53:167-170.
8. Dayan A.D. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 2003, 86:141-159.
9. WHO. Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months (WHO/CDS/CPE/PVC/2002.4). Geneva: World Health Organization; 2002.
10. Bosompem K.M., Bentum I.A., Otchere J., et al. Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health 2004, 9:917-922.
11. Guyatt H.L., Brooker S., Donnelly C.A. Can prevalence of infection in school-aged children be used as an index for assessing community prevalence?. Parasitology 1999, 118:257-268.
12. Odogwu S.E., Ramamurthy N.K., Kabatereine N.B., et al. Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 2006, 100:315-326.
13. Stothard J.R., Sousa-Figueiredo J.C., Standley C., et al. An evaluation of urine-CCA strip test and fingerprick blood SEA-ELISA for detection of urinary schistosomiasis in schoolchildren in Zanzibar. Acta Trop 2009, 111:64-70.
14. Beanland T.J., Lacey S.D., Melkman D.D., et al. Multimedia materials for education, training, and advocacy in international health: experiences with the Schistosomiasis Control Initiative CD-ROM. Mem Inst Oswaldo Cruz 2006, 101(Suppl 1):87-90.
15. Woolhouse M.E.J., Mutapi F., Ndhlovu P.D., Chandiwana S.K., Hagan P. Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology 2000, 120:37-44.
16. Engels D., Chitsulo L., Montresor A., Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 2002, 82:139-146.
17. Balen J., Stothard J.R., Kabatereine N.B., et al. Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 2006, 100:1039-1048.
18. Garba A., Barkire N., Djibo A., et al. Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop 2010, 115:212-219.
19. Sousa-Figueiredo J.C., Day M., Betson M., et al. Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis. J Helminthol 2010, 85:325-333.
20. Chu T.B., Liao C.W., D'Lamini P., et al. Prevalence of Schistosoma haematobium infection among inhabitants of Lowveld, Swaziland, an endemic area for the disease. Trop Biomed 2010, 27:337-342.
21. Saathoff E., Olsen A., Magnussen P., Kvalsvig J.D., Becker W., Appleton C.C. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect Dis 2004, 4:40.
22. Stothard J.R., Gabrielli A.F. Schistosomiasis in African infants and preschool children: to treat or not to treat?. Trends Parasitol 2007, 23:83-86.
23. Johansen M.V., Sacko M., Vennervald B.J., Kabatereine N.B. Leave children untreated and sustain inequity!. Trends Parasitol 2007, 23:568-569. author reply 9-70.
24. Hall A., Nokes C., Wen S.T., et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans R Soc Trop Med Hyg 1999, 93:653-658.
25. Montresor A., Engels D., Chitsulo L., Bundy D.A.P., Brooker S., Savioli L. Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2001, 95:542-544.
26. Montresor A., Odermatt P., Muth S. The WHO dose pole for the administration of praziquantel is also accurate in non-African populations. Trans R Soc Trop Med Hyg 2005, 99:78-81.
27. Sousa-Figueiredo J.C., Pleasant J., Day M., et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2010, 2:103-113.
28. WHO WHO model prescribing information. Drugs used in parasitic diseases 1995, World Health Organization, Geneva. 2nd ed.
29. Stothard J.R., Sousa-Figueiredo J.C., Betson M., et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitol 2011, 138:1593-1606.
30. Sousa-Figueiredo J.C., Day M., Betson M., Kabatereine N.B., Stothard J.R. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel. Trans R Soc Trop Med Hyg 2010, 104:740-742.
31. Taylor P., Murare H.M., Manomano K. Efficacy of low-doses of praziquantel for Schistosoma mansoni and S. haematobium. J Trop Med Hyg 1988, 91:13-17.
32. WHO WHO model formulary 2004, World Health Organization, Geneva.
33. Fenwick A., Savioli L., Engels D., Robert Bergquist N., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 2003, 19:509-515.
34. WHO Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee 2002, World Health Organization, Geneva.
35. Fenwick A. Waterborne infectious diseases-could they be consigned to history?. Science 2006, 313:1077-1081.
36. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008, 21:659-667.
37. Danso-Appiah A., De Vlas S.J. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 2002, 18:125-129.
38. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health 2000, 5:771-778.
39. Renganathan E., Cioli D. An international initiative on praziquantel use. Parasitol Today 1998, 14:390-391.
40. N'Goran E.K., Gnaka H.N., Tanner M., Utzinger J. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Cote d'Ivoire. Ann Trop Med Parasitol 2003, 97:37-51.
41. Armitage P., Berry G. Statistical methods in medical research 1994, Blackwell Scientific Publications, Oxford. 3rd ed.
42. Fisher R.A. On the interpretation of Chi-square from contingency tables and the calculation of P. J R Stat Soc 1922, 85:87-94.
43. Akaike H. Information theory and an extension of the maximum likelihood principle. Second International Symposium on Information Theory 1973, 267-281. Akademiai Kiado, Budapest. B. Petrov, F. Csaki (Eds.).
44. Green H.K., Sousa-Figueiredo J.C., Basanez M.G., et al. Anaemia in Ugandan preschool-aged children: the relative contribution of intestinal parasites and malaria. Parasitol 2011, 138:1534-1545.